Search Results
10
Everything
KOIL Energy Announces Delay in Filing of Annual Report on Form 10-K and anticipates reporting profitable growth in revenues
March 29, 2025 22:31 ET
|
Koil Energy Solutions, Inc.
KOIL Energy Announces Delay in Filing of Annual Report on Form 10-K and anticipates reporting profitable growth in revenues
Aureus Greenway Holdings Inc. Releases Fiscal Year 2024 Financial Results
March 28, 2025 16:01 ET
|
Aureus Greenway Holdings Inc.
Kissimmee, FL, March 28, 2025 (GLOBE NEWSWIRE) -- Aureus Greenway Holdings Inc. (the “Company”) (NASDAQ: AGH), announced today that it has released its financial results for the year ended December...
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
March 28, 2025 08:30 ET
|
Checkpoint Therapeutics, Inc
WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced...
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
March 28, 2025 07:00 ET
|
CG Oncology Inc.
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
60 Degrees Pharmaceuticals Announces 2024 Annual Results
March 28, 2025 06:59 ET
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharmaceuticals (SXTP) reported 140% revenue growth in 2024, driven by Arakoda® sales. Clinical trials and market expansion efforts continue.
Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025
March 27, 2025 16:30 ET
|
Tilray Brands, Inc.
NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company...
KULR Reports Record Fourth Quarter Revenue and Full-Year 2024 Financial Results
March 27, 2025 16:15 ET
|
KULR Technology Group, Inc.
KULR Technology Group, Inc. (NYSE American: KULR) today announced its financial results for the fourth quarter and full-year 2024.
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
March 27, 2025 07:30 ET
|
Arbutus Biopharma Corporation
Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September...
Discovery Reports Fourth Quarter & Full-Year 2024 Financial Results
March 26, 2025 22:32 ET
|
Discovery Silver Corp.
TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced financial results for the three months (“Q4 2024”) and...
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025 16:01 ET
|
Journey Medical Corporation
FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended...